Suppr超能文献

中国儿童流感相关性脑炎/脑炎的特征和结局。

Characteristics and outcome of influenza-associated encephalopathy/encephalitis among children in China.

机构信息

Department of Pediatric Intensive Care Unit, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, China.

Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, China; Department of Medical Record Management, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

出版信息

Clinics (Sao Paulo). 2024 Aug 2;79:100475. doi: 10.1016/j.clinsp.2024.100475. eCollection 2024.

Abstract

BACKGROUND

Influenza-Associated Encephalopathy/Encephalitis (IAE) is characterized by high incidence and poor prognosis. The aim of this study is to describe the clinical features and outcomes of IAE in pediatric patients.

METHODS

We performed a retrospective review of hospitalized cases of laboratory-confirmed influenza infection between January 2018 and December 2021. Demographic, clinical, imaging, treatment and outcome data were collected. Statistical analysis was performed using SPSS software.

RESULTS

Of 446 children hospitalized with influenza, 71 cases were identified with a diagnosis of IAE. The median age was 3 years and 46 (64.8 %) were younger than 5 years. Only one patient was vaccinated for seasonal influenza. 46 (64.8 %) patients had abnormal electroencephalogram examination and 47 (66.2 %) had abnormal brain MRI or CT findings. 68 (95.8 %) patients were treated with oseltamivir/peramivir. 12 (16.9 %) patients suffered mortality. Non-survivors were more likely to have lower Glasgow coma score (median 7), longer duration of fever (median 3 days), with underlying medical conditions (P = 0.006), and complications including sepsis (P = 0.003), shock (P < 0.001), respiratory failure (P = 0.006), acute renal failure (P = 0.001), myocardial damage (P < 0.001), coagulation disorders (P = 0.03), electrolyte disturbance (P = 0.001) and hyperlactacidemia (P = 0.003). Non-survivors had higher percentages of corticosteroids (P = 0.003) and immunoglobulin (P = 0.003) treatments compared to survivors.

CONCLUSIONS

Children with IAE have a high mortality rate. Lower Glasgow coma score, longer duration of fever, with underlying medical conditions and complications pose a great risk to poor prognosis. Influenza vaccination is recommended to all eligible children.

摘要

背景

流感相关脑病/脑炎(IAE)具有发病率高和预后差的特点。本研究旨在描述儿科患者 IAE 的临床特征和结局。

方法

我们对 2018 年 1 月至 2021 年 12 月期间住院的实验室确诊流感感染病例进行了回顾性分析。收集了人口统计学、临床、影像学、治疗和结局数据。使用 SPSS 软件进行了统计分析。

结果

在因流感住院的 446 名儿童中,有 71 例被诊断为 IAE。中位年龄为 3 岁,46 例(64.8%)年龄小于 5 岁。仅有 1 例患者接种了季节性流感疫苗。46 例(64.8%)患者的脑电图检查异常,47 例(66.2%)患者的脑 MRI 或 CT 检查异常。68 例(95.8%)患者接受了奥司他韦/帕拉米韦治疗。12 例(16.9%)患者死亡。非幸存者更有可能出现较低的格拉斯哥昏迷评分(中位数为 7)、较长的发热持续时间(中位数为 3 天)、存在基础疾病(P=0.006),以及合并感染性休克(P=0.003)、脓毒症(P=0.003)、呼吸衰竭(P=0.006)、急性肾损伤(P=0.001)、心肌损伤(P<0.001)、凝血功能障碍(P=0.03)、电解质紊乱(P=0.001)和高乳酸血症(P=0.003)等并发症。与幸存者相比,非幸存者使用皮质类固醇(P=0.003)和免疫球蛋白(P=0.003)治疗的比例更高。

结论

IAE 患儿死亡率高。较低的格拉斯哥昏迷评分、较长的发热持续时间、存在基础疾病和并发症是预后不良的危险因素。建议所有符合条件的儿童接种流感疫苗。

相似文献

1
Characteristics and outcome of influenza-associated encephalopathy/encephalitis among children in China.
Clinics (Sao Paulo). 2024 Aug 2;79:100475. doi: 10.1016/j.clinsp.2024.100475. eCollection 2024.
2
Neuraminidase inhibitors for preventing and treating influenza in adults and children.
Cochrane Database Syst Rev. 2014 Apr 10;2014(4):CD008965. doi: 10.1002/14651858.CD008965.pub4.
4
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965. doi: 10.1002/14651858.CD008965.pub3.
5
Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD002744. doi: 10.1002/14651858.CD002744.pub4.
6
[Clinical features and prognosis of children with influenza-associated encephalopathy: an analysis of 23 cases].
Zhongguo Dang Dai Er Ke Za Zhi. 2025 Jul 15;27(7):829-833. doi: 10.7499/j.issn.1008-8830.2412117.
8
Neuraminidase inhibitors for preventing and treating influenza in children.
Cochrane Database Syst Rev. 2012 Jan 18;1:CD002744. doi: 10.1002/14651858.CD002744.pub3.
9
Intravenous immunoglobulin for the treatment of childhood encephalitis.
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD011367. doi: 10.1002/14651858.CD011367.pub2.
10
Vaccines for preventing influenza in healthy children.
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004879. doi: 10.1002/14651858.CD004879.pub5.

本文引用的文献

2
Severe Influenza-Associated Neurological Disease in Australian Children: Seasonal Population-Based Surveillance 2008-2018.
J Pediatric Infect Dis Soc. 2022 Dec 28;11(12):533-540. doi: 10.1093/jpids/piac069.
4
Clinical Spectrum and Burden of Influenza-Associated Neurological Complications in Hospitalised Paediatric Patients.
Front Pediatr. 2022 Jan 20;9:752816. doi: 10.3389/fped.2021.752816. eCollection 2021.
5
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
7
Influenza-Associated Neurologic Complications in Hospitalized Children.
J Pediatr. 2021 Dec;239:24-31.e1. doi: 10.1016/j.jpeds.2021.07.039. Epub 2021 Jul 20.
8
Prevalence, Risk Factors, and Outcomes of Influenza-Associated Neurologic Complications in Children.
J Pediatr. 2021 Dec;239:32-38.e5. doi: 10.1016/j.jpeds.2021.06.075. Epub 2021 Jul 1.
10
[Estimating the disease burden of seasonal influenza in China, 2006-2019].
Zhonghua Yi Xue Za Zhi. 2021 Mar 2;101(8):560-567. doi: 10.3760/cma.j.cn112137-20201210-03323.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验